Execution Chemicals Preparation and Administration

IDAHO DEPARTMENT OF CORRECTION
Execution Chemicals Preparation and Administration
Updated 06/08/2026
Execution Chemicals Preparation and Administration
Page 1 of 16

A. Modifications to Protocols and Procedures
There must be no deviation from the procedures, chemicals, or chemical sequences in this
protocol without prior consent from the Director of IDOC. A member of the Administrative
Team must monitor and ensure compliance with protocols and procedures related to the
preparation and administration of chemicals.
B. Execution Unit
There must be sufficient lighting and physical space in the Medical Team Room, the
Execution Preparation Room, and the Execution Chamber to enable the Medical Team to
function properly and to observe the condemned person. The Medical Team will monitor
the condemned person during the execution process with the aid of a telescoping color
camera as well as fixed cameras. The cameras will broadcast to the Medical Team Room on
color monitors. The condemned person will be positioned on the gurney and in the
Execution Chamber to enable the Medical Team Leader to view the condemned person’s
intravenous (IV) location and face during the administration of execution chemicals until
completion of the execution.
C. Preparation of Chemicals and Syringes
1. At the appropriate time, the IMSI Warden will transfer custody of the chemicals to
the Medical Team Leader. The Medical Team Leader will supervise all activities
related to chemical preparation and syringe preparation.
2. The Medical Team Leader shall assign a Medical Team member to prepare a set of
syringes for primary set A, backup set B, and backup set C. The assigned Medical
Team member shall prepare and label a set of sterile syringes in a distinctive
manner identifying the specific chemical contained in each syringe by (a) assigned
number, (b) chemical name, (c) chemical amount, and (d) the designated color, as
set forth in the chemical chart below. This information must be preprinted on a
label, with two (2) labels affixed to each syringe to ensure a label remains visible.
3. After the Medical Team Members have prepared and labeled the three (3) sets of
syringes as described above, the Medical Team Leader will place the three (3)
complete sets of syringes in the color-coded and labeled syringe trays in the order in
which the chemicals are to be administered. The syringes will be placed in the color-
coded and labeled syringe trays in a manner to ensure there is no crowding, with
each syringe resting in its corresponding place in the shadow box which is labeled
with the name of the chemical, color, chemical amount, and the designated syringe
number. The syringes must be placed in such a manner to ensure the syringe labels
are clearly visible.
4. After all syringes are prepared and placed in the color-coded and labeled syringe
trays in proper order, the Medical Team Leader must confirm that all syringes are
properly labeled and placed in the color-coded and labeled syringe trays in the order
in which the chemicals are to be administered as designated by the applicable
chemical chart.
5. After intravenous (IV) access is established via primary and backup peripheral
catheters or a central venous line catheter, the Medical Team Leader will supervise
the Medical Team Member assigned to draw chemical set A. The assigned Medical
IDAHO DEPARTMENT OF CORRECTION
Execution Chemicals Preparation and Administration
Updated 06/08/2026
Execution Chemicals Preparation and Administration
Page 2 of 16

Team Member will draw the chemical into the properly labeled syringe as designated
by the applicable chemical chart. After drawing each syringe, the properly labeled
syringe will be placed back in the color-coded and labeled syringe tray in the order
in which the chemicals are to be administered as designated by the applicable
chemical chart. If backup chemical set B or backup chemical set C become
necessary as described further herein, the assigned Medical Team Member will draw
the chemicals for those sets in a similar manner.
6. Primary chemical set A will be drawn after (IV) access is established and before the
execution process commences. The chemicals for back up chemical set B and/or C
must be present and readily available to the Medical Team. Back up chemicals will
only be drawn if deemed necessary by the Medical Team Leader.
7. After the assigned Medical Team Member draws primary set A, the Medical Team
Leader will notify the IMSI Warden that the Medical Team is ready to proceed with
the execution.
Note: All of the open or drawn chemicals must be used or properly disposed of no later
than 24 hours after the time designated for the execution to occur.
Note: Should a stay delay the execution beyond 24 hours of the scheduled execution,
another primary set of syringes must be prepared when the execution is rescheduled in
accordance with the process set forth in this procedure. The replacement primary set of
syringes will then be drawn in accordance with the process set forth in this procedure.
D. Approved Chemicals
1. IDOC has four (4) options for lethal injection methods. The option used is dependent
upon the availability of execution chemicals.
2. The Director has approved the following lethal injection chemicals and methods as
described in Chemical Chart 1, Chemical Chart 2, Chemical Chart 3, and Chemical
Chart 4:
Method 1

CHEMICAL CHART 1
Primary SET A
GREEN
GREEN
GREEN
GREEN
BLACK
BLUE
BLUE
BLACK
RED
RED
BLACK
IDAHO DEPARTMENT OF CORRECTION
Execution Chemicals Preparation and Administration
Updated 06/08/2026
Execution Chemicals Preparation and Administration
Page 3 of 16

CHEMICAL CHART 1 CHEMICAL CHART 1
Backup Set B Backup Set C
1B (complete 1-4)GREEN 1C (complete 1-4) GREEN
GREEN GREEN
GREEN GREEN
GREEN GREEN
BLACK BLACK
BLUE BLUE
BLUE BLUE
BLACK BLACK

RED

RED
RED RED
BLACK BLACK
Syringe Preparation (Method 1)
Syringes 1A, 2A, 3A, 4A, 1B, 2B, 3B, 4B, 1C, 2C, 3C, and 4C each contain 1.25 gm of
sodium pentothal 50 ml of sterile water in four (4) 60 ml. syringes for a total dose of 5
grams of sodium pentothal in each set. Each syringe containing sodium pentothal will
have a GREEN label which contains the name of chemical, chemical amount, and the
designated syringe number.
Syringes 5A, 8A, 11A, 5B, 8B, 11B, 5C, 8C and 11C each contain 60 ml. of a saline
solution and will have a BLACK label which contains the name of the chemical,
chemical amount, and the designated syringe number.
Syringes 6A, 7A, 6B, 7B, 6C and 7C each contain 60 mg of pancuronium bromide for a
total of 120 mg of pancuronium bromide in each set. Each syringe containing
pancuronium bromide will have a BLUE label which contains the name of the chemical,
chemical amount, and the designated syringe number.
Syringes 9A, 10A, 9B, 10B, 9C and 10C each contain 120 milliequivalents of potassium
chloride for a total of 240 milliequivalents of potassium chloride in each set. Each
syringe containing potassium chloride will have a RED label which contains the name of
the chemical, chemical amount, and the designated syringe number.
After the Medical Team prepares the syringes and draws the chemical for primary set A,
the Medical Team Leader shall enter the chamber and attach the IV tubing to the
catheter site.

IDAHO DEPARTMENT OF CORRECTION
Execution Chemicals Preparation and Administration
Updated 06/08/2026
Execution Chemicals Preparation and Administration
Page 4 of 16

Method 2
Syringe No. Label
1A (compete 1-2) 2.5 g Pentobarbital
2A (complete 1-2) 2.5 g Pentobarbital
3A (flush) 60mL Saline,
4A (complete 4-5) 60mg Pancuronium Bromide,
5A (complete 4-5) 60mg Pancuronium Bromide,
6A (flush) 60mL Saline,
7A (complete 7-8) 120mEq Potassium Chloride,
8A (complete 7-8) 120mEq Potassium Chloride,
9A (flush) 60mL Saline,
CHEMICAL CHART 2 CHEMICAL CHART 2
Backup Set B Backup Set C
GREEN GREEN
GREEN GREEN
BLACK BLACK
BLUE BLUE
BLUE BLUE
BLACK BLACK
RED RED
RED RED
BLACK BLACK
Syringe Preparation (Method 2)
Syringes 1A, 2A, 1B, 2B, 1C, and 2C each contain 2.5 gm of pentobarbital for a total of
5 grams in each set. Each syringe containing pentobarbital will have a GREEN label
which contains the name of chemical, chemical amount and the designated syringe
number.
Syringes 3A, 6A, 9A, 3B, 6B, 9B, 3C, 6C and 9C each contain 60 ml. of a saline solution
and will have a BLACK label which contains the name of the chemical, chemical
amount and the designated syringe number.
Syringes 4A, 5A, 4B, 5B, 4C and 5C each contain 60 mg of pancuronium bromide for a
total of 120 mg of pancuronium bromide in each set. Each syringe containing
pancuronium bromide will have a BLUE label which contains the name of the chemical,
chemical amount and the designated syringe number.
Syringes 7A, 8A, 7B, 8B, 7C and 8C each contain 120 milliequivalents of potassium
chloride for a total of 240 milliequivalents of potassium chloride in each set. Each
syringe containing potassium chloride will have a RED label which contains the name of
the chemical, chemical amount and the designated syringe number.
After the Medical Team prepares the syringes and draws the chemical for primary set A,
the Medical Team Leader shall enter the chamber and attach the IV tubing to the
catheter site.
IDAHO DEPARTMENT OF CORRECTION
Execution Chemicals Preparation and Administration
Updated 06/08/2026
Execution Chemicals Preparation and Administration
Page 5 of 16

Method 3
CHEMICAL CHART 3
Primary Set A
Syringe No. Label
1A (complete 1-4) GREEN
GREEN
GREEN
GREEN
BLACK
CHEMICAL CHART 3 CHEMICAL CHART 3
Backup Set B Backup Set C
1B (complete 1-4)GREEN 1C (complete 1-4) GREEN
GREEN GREEN
GREEN GREEN
GREEN GREEN
BLACK BLACK
Syringe Preparation (Method 3)
Syringes 1A, 2A, 3A, 4A, 1B, 2B, 3B, 4B, 1C, 2C, 3C, and 4C each contain 1.25 g of
sodium pentothal in 50 ml of sterile water in four (4) 60 ml syringes for a total dose of
5 grams of sodium pentothal in each set. Each syringe containing sodium pentothal will
have a GREEN label which contains the name of chemical, chemical amount, and the
designated syringe number.
Syringes 5A, 5B, and 5C each contain 60 ml. of a saline solution and will have a BLACK
label which contains the name of the chemical, chemical amount, and the designated
syringe number.
After the Medical Team prepares the syringes and draws the chemical for primary set A,
the Medical Team Leader shall enter the chamber and attach the IV tubing to the
catheter site.
Method 4
CHEMICAL CHART 4
Primary Set A
Syringe No. Label
1A (complete 1-2) 2.5 g Pentobarbital GREEN
2A (complete 1-2) 2.5 g Pentobarbital GREEN
3A (flush) 60mL Saline, BLACK
IDAHO DEPARTMENT OF CORRECTION
Execution Chemicals Preparation and Administration
Updated 06/08/2026
Execution Chemicals Preparation and Administration
Page 6 of 16

CHEMICAL CHART 4 CHEMICAL CHART 4
Backup Set B Backup Set C
GREEN GREEN
GREEN GREEN
BLACK BLACK
Syringe Preparation (Method 4)
Syringes 1A, 2A, 1B, 2B, 1C, and 2C each contain 2.5 gm of pentobarbital for a total of
5 grams in each set. Each syringe containing pentobarbital will have a GREEN label
which contains the name of chemical, chemical amount and the designated syringe
number.
Syringes 3A, 3B, and 3C each contain 60 ml. of a saline solution and will have a BLACK
label which contains the name of the chemical, chemical amount and the designated
syringe number.
After the Medical Team prepares the syringes and draws the chemical for primary set A,
the Medical Team Leader shall enter the chamber and attach the IV tubing to the
catheter site.
Note: The chemical amounts as set forth in chemical charts 1, 2, 3, and 4 are
designated for the execution of persons weighing 500 pounds or less. The chemical
amounts will be reviewed and may be revised as necessary if weight exceeds 500
pounds.
Note: The full dose contained in each syringe of the chemical set in use must be
administered to the condemned person and subsequently documented by the
designated recorder. The quantities of the chemicals drawn and administered may not
be changed in any manner without prior approval of the Director after consultation with
the Medical Team Leader. If all electrical activity of the heart ceases prior to
administering all of the chemicals in the set, the Medical Team members must continue
to follow this protocol and administer all remaining chemicals in the set being used in
the order and amounts set forth in the applicable chemical chart.
E. Preparation, Movement, and Monitoring of the Condemned Person
1. The condemned person will be offered a mild sedative. The sedative must be
provided to the condemned person no later than four hours prior to the execution
unless it is determined medically necessary.
2. Prior to moving the condemned person from the isolation cell to the Execution
Preparation Room, the Director will confer with the Idaho Attorney General, or
designee, and the Idaho Governor, or designee, to confirm there is no legal
impediment to proceeding with the lawful execution.
3. The witnesses will be escorted to the designated witness areas.
4. At the designated time, the Escort Team will secure the condemned person to the
medical gurney. After the condemned person has been secured to the medical
gurney, the Escort Team Leader will personally check the restraints which secure the
condemned person to the medical gurney to ensure they are not so restrictive as to
IDAHO DEPARTMENT OF CORRECTION
Execution Chemicals Preparation and Administration
Updated 06/08/2026
Execution Chemicals Preparation and Administration
Page 7 of 16

impede the condemned person’s circulation, yet sufficient to prevent manipulation of
the catheters and IV lines. The Escort Team will move the condemned person to the
Execution Preparation Room.
5. The IMSI Warden or designee will confirm audio and video feeds from the Execution
Preparation Room and the Execution Chamber are functioning and transmitting to
the witness areas prior to the condemned person being moved from their cell. The
microphones in the Execution Preparation Room and Execution Chamber will be
positioned to broadcast any utterances or noises made by the condemned person.
The audio and video feeds from the Execution Preparation Room will continue to
transmit to the witness areas through the duration of the preparation process. After
peripheral or central line venous access has been established, the Escort Team
Leader will again check the restraints which secure the condemned person to the
medical gurney to ensure they are not so restrictive as to impede the condemned
person’s circulation, yet sufficient to prevent manipulation of the catheters and IV
lines. The designated Medical Team Member will affix the EKG leads at appropriate
locations on the condemned person. The Escort Team will move the condemned
person to the Execution Chamber on the medical gurney.
6. Once the medical gurney is secured in the Execution Chamber, the Medical Team
Leader will attach the leads to the electrocardiograph (EKG) monitor and confirm
that the EKG monitor is functioning properly. The Medical Team Leader will ensure
the proper graph paper is used. A backup EKG monitor must be on-site and readily
available if necessary. The Medical Team Leader will then attach the IV lines to the
established venous access catheter sites and ensure they are flowing appropriately.
7. The Medical Team Leader will assign a Medical Team Member to monitor the EKG.
The assigned Medical Team Member will observe the EKG monitor and mark the EKG
graph paper at the commencement and completion of the administration of each
chemical along with their assigned identifier.
8. Throughout the execution procedure, the Medical Team Leader and the Medical Team
Member assigned to monitor the EKG are responsible for monitoring the condemned
person’s level of consciousness. The remaining Medical Team Members will maintain
continual observation of the condemned person using one or more of the following
methods: direct observation, audio equipment, video equipment, and television
monitor as well as any other approved method(s) deemed necessary by the Medical
Team Leader.
9. The Medical Team Leader will confirm the video and audio feeds in the Execution
Chamber are functioning properly and transmitting to the Medical Team Room. The
audio and video feeds will continue to transmit to the Medical Team Room
throughout the execution process. The audio feed from the Execution Chamber will
continue to transmit to the witness areas throughout the execution process.
10. The IMSI Warden must ensure there is a person present in the Execution Chamber
throughout the execution who is able to communicate with the condemned person in
their primary language. This person will be positioned to clearly see, hear, and
speak to the condemned person throughout the execution. If able to communicate
with the condemned person in their primary language, the IMSI Warden may serve
in that capacity.
IDAHO DEPARTMENT OF CORRECTION
Execution Chemicals Preparation and Administration
Updated 06/08/2026
Execution Chemicals Preparation and Administration
Page 8 of 16

11. Once the condemned is prepared, the IMSI Warden must read aloud a summary of
the death warrant.
12. The IMSI Warden will then ask the condemned person if they wish to make a last
statement and provide an opportunity to do so.
13. The IMSI Warden will offer the condemned person eye covering.
F. Intravenous Lines
1. Intravenous (IV) catheters necessary to carry out the execution will be inserted in
the Execution Preparation Room.
2. The assigned Medical Team Members will determine the best sites on the condemned
person to insert IV catheters. Peripheral venous access is the preferred method of IV
catheter placement, unless the Medical Team Leader determines it is not possible to
place two reliable peripheral catheters. If using peripheral venous access, a primary
and backup IV catheter will be placed. If utilizing central line venous access as
directed by the Medical Team Leader, a single IV catheter will be placed. All IV
catheter insertions will be inserted by appropriately trained and certified or licensed
persons using their professional training and experience. The peripheral insertion
sites in order of preference will be arms, hands, ankles, and feet, with placement
determined by the Medical Team Leader.
3. The Medical Team will make every reasonable effort to ensure that no unnecessary
pain or suffering is inflicted on the condemned person during the IV catheter
insertion process. At the discretion of the Medical Team Leader, the Medical Team
may use a localized anesthetic to numb the venous access site.
4. To ensure proper insertion in the vein, the assigned Medical Team Members should
confirm the flashback of blood at the catheter hub.
5. Prior to leaving the Execution Preparation Room, the assigned Medical Team
Members must ensure the catheter is properly secured with the use of tape or
adhesive material and/or sutures (if necessary) out of reach of the condemned
person’s hands.
6. Once the condemned person is moved into the Execution Chamber and the Medical
Team Leader has attached the IV lines to the inserted IV catheter(s), a flow of saline
will be started in each line and administered at a slow rate to keep the line open.
7. Should it be determined that the use of the backup IV catheter is necessary, a
complete set of backup chemicals will be administered in the backup IV as set forth
in the applicable chemical chart.
G. Administration of Chemicals
1. The primary peripheral IV catheter or central line catheter will be used to administer
the chemicals. Any failure of a venous access line must be immediately reported to
the IMSI Warden. If directed to proceed, the backup peripheral IV catheter will be
utilized.
2. The IV catheter or central line in use must not be covered and must remain visible
throughout the entire execution process.
IDAHO DEPARTMENT OF CORRECTION
Execution Chemicals Preparation and Administration
Updated 06/08/2026
Execution Chemicals Preparation and Administration
Page 9 of 16

3. The IMSI Warden must physically remain in the Execution Chamber with the
condemned person throughout the administration of the chemicals. The IMSI
Warden must remain in a position sufficient to clearly observe the condemned
person and all IV sites for any potential problems and must immediately notify the
Medical Team Leader and Director should any issue occur. Upon receipt of such
notification, the Director will stop the proceedings, consult with the Medical Team
Leader, and then direct the Medical Team to continue the execution process or
discontinue the execution. The Medical Team Leader must appoint a Medical Team
recorder. The Medical Team recorder is responsible for completing the applicable
sequence of chemical form (see appendices 1 through 4). The recorder must
document on the form the amount of each chemical administered and confirm that it
was administered in the order set forth in the chemical chart. Any deviation from the
written procedure must be noted and explained on the form.
4. At the time the execution is to commence and prior to administering the chemicals,
the Director will confirm with the Idaho Attorney General, or designee, and the
Idaho Governor, or designee, that there is no impediment to proceeding with the
execution. Upon receipt of confirmation that there is no impediment, the Director
will instruct the IMSI Warden to commence the process to carry out the sentence of
death. If there is an impediment to the execution, the Director must instruct the
IMSI Warden to stop the process and to notify the condemned person and witnesses
that the execution has been stayed or delayed. The IMSI Warden, or designee, will
notify the IDOC Public Information Officer and other staff as necessary.
5. Upon receiving the order to commence the execution process from the Director, the
IMSI Warden will instruct the Medical Team Leader to begin administering the
chemicals.
Methods 1 and 2

1. The Medical Team Leader will instruct the assigned Medical Team member to begin
dispensing the first chemical.
2. Upon direction from the Medical Team Leader, the assigned Medical Team member
will visually and verbally confirm the chemical name on the syringe and then
administer the full dose of either sodium pentothal/or pentobarbital immediately
followed by the saline flush. The saline is administered as a secondary precaution to
further ensure the line is functioning properly and flushed between each chemical.
3. After the sodium pentothal/or pentobarbital and saline have been administered and
before the Medical Team members begin administering the pancuronium bromide,
the Medical Team Leader must confirm the condemned person is unconscious by
direct examination. The Medical Team Leader, dressed in a manner to preserve
anonymity, will enter the Execution Chamber to physically confirm the condemned
person is unconscious by using all necessary and appropriate techniques such as
giving verbal stimulus, soliciting an auditory response, touching the eyelashes,
conducting a sternal rub. The Medical Team Leader will also confirm that the IV line
remains affixed and functioning properly.
4. No further chemicals will be administered until the Medical Team Leader has
confirmed the condemned person is unconscious. After three minutes have elapsed
since the administration of the sodium pentothal/or pentobarbital, the Medical Team
IDAHO DEPARTMENT OF CORRECTION
Execution Chemicals Preparation and Administration
Updated 06/08/2026
Execution Chemicals Preparation and Administration
Page 10 of 16

Leader will assess and confirm that the condemned person is unconscious. The
Medical Team Leader will verbally advise the IMSI Warden of the condemned
person’s status.
5. If the condemned person is conscious, the Medical Team must assess the situation to
determine the reason, if possible. The Medical Team Leader must communicate this
information to the IMSI Warden, along with all Medical Team input. The Director will
determine how to proceed, including whether to start the procedure over at a later
time or stand down.
6. If deemed appropriate, the IMSI Warden may instruct the Medical Team to
administer an additional 5 grams of sodium pentothal/or pentobarbital followed by
the saline flush from backup set B.
7. Upon administering the sodium pentothal/or pentobarbital and saline from backup
set B, the Medical Team Leader will again physically confirm the condemned person
is unconscious and verbally advise the IMSI Warden of the same. Throughout the
entire procedure, the Medical Team members and the IMSI Warden will continually
monitor the condemned person using all available means to ensure that the
condemned person remains unconscious and that there are no complications.
8. Only after receiving oral confirmation from the Medical Team Leader that the
condemned person is unconscious and three minutes have elapsed since
commencing the administration of the sodium pentothal/or pentobarbital and saline
from backup set B, will the IMSI Warden instruct the Medical Team Leader to
proceed with administering the next chemicals.
9. When directed by the IMSI Warden, the Medical Team Leader will instruct the
assigned Medical Team members to begin administering the full doses of the
remaining chemicals (pancuronium bromide and potassium chloride), each followed
by a saline flush as set forth in the applicable chemical chart.
10. If after administering the potassium chloride and subsequent saline flush, the
electrical activity of the condemned person’s heart has not ceased, the additional
potassium chloride and saline flush contained in backup set B must be administered.
Methods 3 and 4

1. The Medical Team Leader will instruct the assigned Medical Team member to begin
dispensing the first chemical.
2. Upon direction from the Medical Team Leader, the assigned Medical Team member
will visually and verbally confirm the chemical name on the syringe and then
administer the full dose of either sodium pentothal/or pentobarbital immediately
followed by the saline flush.
3. If after administering the sodium pentothal/or pentobarbital and subsequent saline
flush in set A, and 10 minutes have elapsed, and the electrical activity of the
condemned person’s heart has not ceased, the Medical Team will draw chemical for
backup set B. The additional sodium pentothal/or pentobarbital and saline flush
contained in backup set B shall then be administered.
4. If after administering the sodium pentothal/or pentobarbital and subsequent saline
flush in set B, and 10 minutes have elapsed, and the electrical activity of the
IDAHO DEPARTMENT OF CORRECTION
Execution Chemicals Preparation and Administration
Updated 06/08/2026
Execution Chemicals Preparation and Administration
Page 11 of 16

condemned person’s heart has not ceased, the Medical Team will draw chemical for
backup set C. The additional sodium pentothal/or pentobarbital and saline flush
contained in backup set C shall then be administered.
Completion of Execution for All Methods

1. For chemical set A and chemical set B (if used) and chemical set C (if used), the full
dose contained in each syringe must be administered to the condemned person and
subsequently documented by the designated recorder. The quantities of the
chemicals drawn and administered may not be changed in any manner without prior
approval of the Director after consultation with the Medical Team Leader.
2. If all electrical activity of the heart ceases prior to administering all the chemicals in
the chemical set being administered (A, B, or C), the Medical Team members must
continue to follow this protocol and administer all remaining chemicals in that set in
the order and amounts set forth in the applicable chemical chart.
3. When all electrical activity of the heart has ceased as shown by the EKG monitor, the
Medical Team Leader will advise the Ada County Coroner that the procedure has
been completed. The Medical Team Leader will ensure that the EKG monitor runs a
print-out strip for two minutes after the last chemical is administered.
4. The Ada County Coroner will enter the execution chamber to examine and pronounce
the death of the condemned person. The IMSI Warden will then announce that the
sentence of death has been carried out.
5. The witnesses will be escorted from the Execution Unit back to the respective staging
and exit locations.
H. Documentation of Chemicals and Stay
1. In the event that a pending stay results in more than a two-hour delay, the catheter
may be removed in consultation with the Medical Team Leader and the condemned
person will be returned to the isolation cell until further notice.
2. The Medical Team recorder will account for all chemicals that were drawn but not
administered and document, in the applicable sequence of chemical form (see
appendices 1 through 4), the chemical name, syringe identification code, amount,
date, and the time. Time will be recorded based on the approved Medical Team
Room clock. The Medical Team Leader and the Medical Team recorder each will sign
the applicable sequence of chemical form (see appendices 1 through 4). The Medical
Team Leader will give the unopened, unused chemicals to a member of the
Administrative Team.
3. All logs, the applicable sequence of chemical forms (see appendices 1 through 4), the
list of identifiers, and the EKG monitor tape will be submitted to the designated
member of the Administrative Team responsible for retention.
4. Upon completion of the execution or when a stay exceeding 24 hours is granted, the
Administrative Team will ensure the Medical Team has disposed of all medical waste
and supplies to include unused, drawn chemicals in accordance with state of Idaho
and federal law.
IDAHO DEPARTMENT OF CORRECTION
Execution Chemicals Preparation and Administration
Updated 06/08/2026
Execution Chemicals Preparation and Administration
Page 12 of 16

I. Contingency Procedure
1. A portable cardiac monitor/defibrillator will be readily available on site in the event
that the condemned person goes into cardiac arrest at any time prior to
administering the chemicals; trained medical staff must make every effort to revive
should this occur, unless the condemned person has signed an Idaho Physician
Orders for Scope of Treatment form.
2. Trained medical personnel and emergency transportation will be available in
proximity to respond to the condemned person should any medical emergency arise
at any time before the order to proceed with the execution is issued by the Director.
3. The Director will be immediately notified if any part of the execution process is not
proceeding according to these procedures. The Director will stop the proceedings,
consult with the Medical Team Leader, and then direct the Medical Team to continue
with or discontinue the execution.

IDAHO DEPARTMENT OF CORRECTION
Execution Chemicals Preparation and Administration
Updated 06/08/2026
Execution Chemicals Preparation and Administration
Page 13 of 16

Sequence of Chemical Form – Method 1

Resident: IDOC #: Date:
Chemical Chart 1: PRIMARY SET A
Syringe
No. Label Comments
1.25 g Sodium Pentothal,
1.25 g Sodium Pentothal,
1.25 g Sodium Pentothal,
1.25 g Sodium Pentothal,
60mL Saline,
60mg Pancuronium Bromide,
60mg Pancuronium Bromide,
60mL Saline,
120mEq Potassium Chloride,
120mEq Potassium Chloride,
60mL Saline,

Chemical Chart 1: BACKUP SET B
Syringe
No. Label Comments
1.25 g Sodium Pentothal,
1.25 g Sodium Pentothal,
1.25 g Sodium Pentothal,
1.25 g Sodium Pentothal,
60mL Saline,
60mg Pancuronium Bromide,
60mg Pancuronium Bromide,
60mL Saline,
120mEq Potassium Chloride,
120mEq Potassium Chloride,
60mL Saline,
Label Comments
1.25 g Sodium Pentothal,
1.25 g Sodium Pentothal,
1.25 g Sodium Pentothal,
1.25 g Sodium Pentothal,
60mL Saline,
60mg Pancuronium Bromide,
60mg Pancuronium Bromide,
60mL Saline,
120mEq Potassium Chloride,
120mEq Potassium Chloride,
60mL Saline,
IDAHO DEPARTMENT OF CORRECTION
Execution Chemicals Preparation and Administration
Updated 06/08/2026
Execution Chemicals Preparation and Administration
Page 14 of 16

Sequence of Chemical Form – Method 2
Resident: IDOC #: Date:
Chemical Chart 2: PRIMARY SET A
Syringe
No. Label Comments
2.5 g Pentobarbital
2.5 g Pentobarbital
60mL Saline,
60mg Pancuronium Bromide,
60mg Pancuronium Bromide,
60mL Saline,
120mEq Potassium Chloride,
120mEq Potassium Chloride,
60mL Saline,

Chemical Chart 2: BACKUP SET B
Syringe
No. Label Comments
2.5 g Pentobarbital
2.5 g Pentobarbital
60mL Saline,
60mg Pancuronium Bromide,
60mg Pancuronium Bromide,
60mL Saline,
120mEq Potassium Chloride,
120mEq Potassium Chloride,
60mL Saline,

Chemical Chart 2: BACKUP SET C
Syringe
No. Label Comments
2.5 g Pentobarbital
2.5 g Pentobarbital
60mL Saline,
60mg Pancuronium Bromide,
60mg Pancuronium Bromide,
60mL Saline,
120mEq Potassium Chloride,
120mEq Potassium Chloride,
60mL Saline,

IDAHO DEPARTMENT OF CORRECTION
Execution Chemicals Preparation and Administration
Updated 06/08/2026
Execution Chemicals Preparation and Administration
Page 15 of 16

Sequence of Chemical Form- Method 3
Inmate: IDOC #: Date:
Chemical Chart 3: PRIMARY SET A
Syringe
No. Label Comments
1.25 g Sodium Pentothal,
1.25 g Sodium Pentothal,
1.25 g Sodium Pentothal,
1.25 g Sodium Pentothal,
60mL Saline,

Chemical Chart 3: BACKUP SET B
Syringe
No. Label Comments
1.25 g Sodium Pentothal,
1.25 g Sodium Pentothal,
1.25 g Sodium Pentothal,
1.25 g Sodium Pentothal,
60mL Saline,

Chemical Chart 3: BACKUP SET C
Syringe
No. Label Comments
1.25 g Sodium Pentothal,
1.25 g Sodium Pentothal,
1.25 g Sodium Pentothal,
1.25 g Sodium Pentothal,
60mL Saline,

IDAHO DEPARTMENT OF CORRECTION
Execution Chemicals Preparation and Administration
Updated 06/08/2026
Execution Chemicals Preparation and Administration
Page 16 of 16

Sequence of Chemical Form- Method 4
Inmate: IDOC #: Date:
Chemical Chart 4: PRIMARY SET A
Syringe
No.
Label Time
Administered
Comments
1A GREEN
2A GREEN
3A BLACK

Chemical Chart 4: BACKUP SET B
Syringe
No.
Label Time
Administered
Comments
1B GREEN
2B GREEN
3B BLACK

Chemical Chart 4: BACKUP SET C
Syringe
No.
Label Time
Administered
Comments
1C GREEN
2C GREEN
3C BLACK